Share Name Share Symbol Market Type Share ISIN Share Description
Iq-ai Limited LSE:IQAI London Ordinary Share JE00BD4H0R42 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -3.57% 2.70 2.60 2.80 2.80 2.70 2.80 1,055,788 14:18:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Retailers 0.3 -0.6 -0.5 - 4

IQ-AI Limited Imaging Biometrics Adds to Development Team

27/01/2020 9:29am

UK Regulatory (RNS & others)

Iq-ai (LSE:IQAI)
Historical Stock Chart

From Nov 2019 to May 2020

Click Here for more Iq-ai Charts.


RNS Number : 9880A

IQ-AI Limited

27 January 2020


("IQ-AI" or the "Company")

IQ-AI's Subsidiary Imaging Biometrics Adds to Development Team

IQ-AI is pleased to announce its subsidiary, Imaging Biometrics, LLC (IB), has enlisted the services of Jay Urbain, PhD to its software development team. Dr. Urbain brings significant experience in machine learning, deep learning, and data science, with significant contributions across multiple industrial applications including healthcare.

Dr. Urbain started his career at Marquette Medical Systems (now part of GE Healthcare) and for the past 16 years held the position of professor at the Milwaukee School of Engineering where he developed and taught courses in artificial intelligence and general computer science topics. As an nVidia Certified Deep Learning Instructor, Dr. Urbain conducts deep learning workshops in collaboration with nVidia and his research passion is at the intersection of machine learning and healthcare. He remains an adjunct professor at the Milwaukee School of Engineering as well as at the Medical College of Wisconsin.

Michael Schmainda, non-executive director of IQ-AI, said, "We are very excited that Dr. Urbain has joined IB's development team. His background and expertise dovetail perfectly with IB's existing team of software engineers, and will catalyze the development of new technologies and products".

The Directors of the Company accept responsibility for the contents of this announcement.


For further information, please contact:

 IQ-AI Limited 
  Trevor Brown/Vinod Kaushal/Qu Li 
  Tel: 020 7469 0930 
 Peterhouse Capital Limited (Financial Adviser and Broker) 
  Lucy Williams/Heena Karani 
  Tel: 020 7220 9797 

About IQ-AI Ltd

IQ-AI, Ltd, the parent company of StoneChecker(R) and Imaging Biometrics(R), is focused on advanced and state of the art medical software and services. ( Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

January 27, 2020 04:29 ET (09:29 GMT)

1 Year Iq-ai Chart

1 Year Iq-ai Chart

1 Month Iq-ai Chart

1 Month Iq-ai Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200529 17:47:10